ArticleMolecular therapy. Methods & clinical development2024

A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice.

Madison L Sangster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.